| Bioactivity | SARS-CoV-2-IN-23 (compound GRL-0617) is a SARS-COV-2 papain-like protease (PLpro) inhibitor with an IC50 value of 2.3 μM[1]. |
| Target | IC50: 2.3 μM (SARS-COV-2 PLpro) |
| Name | SARS-CoV-2-IN-23 |
| Formula | C21H22N2O |
| Molar Mass | 318.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ferreira GM, et al. Inhibitor induced conformational changes in SARS-COV-2 papain-like protease. Sci Rep. 2022 Jul 8;12(1):11585. |